{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:16:11Z","timestamp":1793247371508,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pharma.2025.11.002","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T16:50:30Z","timestamp":1762534230000},"page":"382-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Green analytical method development and validation for Flavokawain A using RP-HPLC in bulk and in-house tablet dosage forms"],"prefix":"10.1016","volume":"84","author":[{"given":"Vaishnavi","family":"Pawar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhatu","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrakant","family":"Gawli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqrar","family":"Ahamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0920-1266","authenticated-orcid":false,"given":"Harun M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2025.11.002_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-13-102","article-title":"The flavokawains: uprising medicinal chalcones","volume":"13","author":"Abu","year":"2013","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.pharma.2025.11.002_bib0110","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/jcmm.13973","article-title":"Chalcone flavokawain A attenuates TGF-\u03b21-induced fibrotic pathology via inhibition of ROS\/Smad3 signaling pathways and induction of Nrf2\/ARE-mediated antioxidant genes in vascular smooth muscle cells","volume":"23","author":"Hseu","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.pharma.2025.11.002_bib0115","doi-asserted-by":"crossref","first-page":"116896","DOI":"10.1016\/j.jep.2023.116896","article-title":"Beneficial biological effects of Flavokawain A, a chalcone constituent from kava, on surgically induced endometriosis rat model","volume":"318","author":"Wei","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharma.2025.11.002_bib0120","doi-asserted-by":"crossref","first-page":"747","DOI":"10.5530\/ijper.20257348","article-title":"Cardioprotective role of Flavokawain A against isoproterenol-induced acute myocardial infarction in rats via modulation of NF-?B\/HO-1\/NQO-1 pathways","volume":"59","author":"Wu","year":"2025","journal-title":"Indian J Pharm Educ Res"},{"key":"10.1016\/j.pharma.2025.11.002_bib0125","first-page":"1","article-title":"Biological activity, hepatotoxicity, and structure-activity relationship of Kavalactones and Flavokavins, the two main bioactive components in Kava (Piper methysticum)","volume":"2021","author":"Wang","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.pharma.2025.11.002_bib0130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/molecules22030462","article-title":"Induction of G2M arrest by Flavokawain A, a Kava Chalcone, increases the responsiveness of HER2-overexpressing breast cancer cells to herceptin","volume":"22","author":"Jandial","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.pharma.2025.11.002_bib0135","doi-asserted-by":"crossref","first-page":"e105244","DOI":"10.1371\/journal.pone.0105244","article-title":"Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro","volume":"9","author":"Abu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharma.2025.11.002_bib0140","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-04-3803","article-title":"Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and tumor growth in mice","volume":"65","author":"Zi","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharma.2025.11.002_bib0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13046-022-02500-4","article-title":"Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer","volume":"41","author":"Liu","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.pharma.2025.11.002_bib0150","doi-asserted-by":"crossref","first-page":"113288","DOI":"10.1016\/j.jpba.2020.113288","article-title":"Flavokawain A inhibits prostate cancer cells by inducing cell cycle arrest and cell apoptosis and regulating the glutamine metabolism pathway","volume":"186","author":"Wang","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.pharma.2025.11.002_bib0155","first-page":"379","article-title":"Activity and mechanism of flavokawain A in inhibiting permeability-glycoprotein expression in paclitaxel resistance of lung cancer","volume":"19","author":"Li","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.pharma.2025.11.002_bib0160","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1158\/1538-7445.AM2011-4629","article-title":"Abstract 4629: Ultra performance liquid chromatography (UPLC)-tandem mass spectrometry (MS\/MS) method for analysis and pharmacokinetic study of flavokawain A, a novel chalcone from the kava plant, in mice","volume":"71","author":"Xu","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharma.2025.11.002_bib0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/22297928.2020.1766996","article-title":"Determination of Flavokawain B, in deprotonized rat plasma (after oral administration) with an improved sensitivity by capillary electrophoresis tandem mass spectrometry detection: it's application to pharmacokinetic study","volume":"10","author":"Deepakumari","year":"2020","journal-title":"Anal Chem Lett"},{"key":"10.1016\/j.pharma.2025.11.002_bib0170","article-title":"UPLC\u2013MS\/MS determination of flavokawain B, a novel anti-tumor chemotherapeutic agent in rat plasma and its application to a pharmacokinetic study in rats","volume":"33","author":"Yang","year":"2019","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.pharma.2025.11.002_bib0175","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1002\/jssc.202100198","article-title":"Simultaneous determination of both kavalactone and flavokawain constituents by different single-marker methods in kava","volume":"44","author":"Zhao","year":"2021","journal-title":"J Sep Sci"},{"key":"10.1016\/j.pharma.2025.11.002_bib0180","first-page":"5","article-title":"Validation of analytical procedures\u00a0\u2013\u00a0ICH Q2(R2)","volume":"29","author":"Elder","year":"2024","journal-title":"Eur Pharm Rev"},{"key":"10.1016\/j.pharma.2025.11.002_bib0185","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u00a0\u2013\u00a0Analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal Chem"},{"key":"10.1016\/j.pharma.2025.11.002_bib0190","doi-asserted-by":"crossref","first-page":"101013","DOI":"10.1016\/j.jpha.2024.101013","article-title":"Green analytical chemistry metrics for evaluating the greenness of analytical procedures","volume":"14","author":"Yin","year":"2024","journal-title":"J Pharm Anal"},{"issue":"16","key":"10.1016\/j.pharma.2025.11.002_bib0195","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1055\/a-0637-2400","article-title":"Single-lab validation for determination of Kavalactones and Flavokavains in piper methysticum (Kava)","volume":"84","author":"Liu","year":"2018","journal-title":"Planta Med"},{"issue":"7","key":"10.1016\/j.pharma.2025.11.002_bib0200","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/molecules24071245","article-title":"A UHPLC-UV method development and validation for determining Kavalactones and Flavokavains in piper methysticum (Kava)","volume":"24","author":"Tang","year":"2019","journal-title":"Molecules"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925001798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925001798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:43:58Z","timestamp":1776357838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450925001798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0003450925001798"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2025.11.002","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Green analytical method development and validation for Flavokawain A using RP-HPLC in bulk and in-house tablet dosage forms","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2025.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}